PRVB
Provention Bio Inc
Price:  
24.98 
USD
Volume:  
9,046,640.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRVB WACC - Weighted Average Cost of Capital

The WACC of Provention Bio Inc (PRVB) is 6.0%.

The Cost of Equity of Provention Bio Inc (PRVB) is 6.00%.
The Cost of Debt of Provention Bio Inc (PRVB) is 7.00%.

Range Selected
Cost of equity 5.30% - 6.70% 6.00%
Tax rate 0.60% - 0.80% 0.70%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.4% - 6.7% 6.0%
WACC

PRVB WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.32 0.33
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.30% 6.70%
Tax rate 0.60% 0.80%
Debt/Equity ratio 0.01 0.01
Cost of debt 7.00% 7.00%
After-tax WACC 5.4% 6.7%
Selected WACC 6.0%